Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Prevalence and Prevention Driving Healthcare in Europe Toward Molecular Diagnostics Expansion and Innovation
save 25 %
* Required Fields
Pay by invoice
Across all segments of in-vitro diagnostics, including research and further upcoming disruptive technologies across the life sciences landscape—research tools, clinical diagnostics, and pharma—disruptive technologies transform the complete healthcare decision making and diagnostics trend. However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics companies that fail to capitalize on the opportunities presented through emerging trends and disruptive new business models become late entrants in a market, generally before redundancy from me-too products occurs and take market share. This study provides an elaborate structure of the European healthcare system , which is supporting the growth of molecular diagnostics, the reimbursement strategies, and policies promoting the acceptance of MDx assays across applications. This information would be suitable to understand the current need and the diagnostics style adoption among the patient population for better outcomes and clinical decision making. Specific challenges shared in this study include the shifting payment landscape which pays for services, change in business models, and challenges in innovative therapeutics and molecular diagnostics to align with value-based care models.
Global Drug Discovery and Early Development Outsourcing Growth Opportunities
Global RNA Therapeutics:Technology Growth Opportunities
Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026
Novel Enzyme Technologies for Pharmaceutical Applications
Precision Immunotherapy Innovations Transforming Human Health and Wellness
Global Single Cell Genomics and Proteomics Market, Forecast to 2023
Chinese Clinical Laboratories Market, Forecast to 2025
Vietnamese Clinical Laboratories Market, Forecast to 2025
Breakthroughs in Non-Alcoholic Steatohepatitis Management
Thailand Clinical Laboratories Market, Forecast to 2025
power electronics market
alternative energy market
commercial uav market
wearable technology market
augmented reality market
plastic waste management market
thermal spray coatings market
glucose monitoring devices market
tobacco industry analysis
industrial robotics market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.